The Padamsee Group's Daughter, Sister, Mother Project is distinct from other research in the region and around the country in three primary ways:

First, the researchers study and learn from the experiences of high-risk women themselves. Their projects start from stories, narratives and answers provided by women in order to learn about what they need to make the most empowered and health-protective decisions. This involves using inductive research and sociological methods to translate data about women’s own experiences into recommendations for future changes in clinical practice, health policy and decision support aids.

Starting from women’s own experiences has allowed these researchers to generate new insights about how women make risk-management decisions and how they can be better supported. They’ve found that women’s experiences with the cancers of loved ones make a profound difference in how women think about their own risk, process prevention options and how they make risk-management choices. Women are strongly influenced by close personal exposure to the cancer experience, types of cancers they were exposed to and outcomes of their loved ones’ cancer treatment.

The Padamsee Group experts have also illuminated substantial differences between white and African-American women and how differences in race and ethnicity directly impact awareness, knowledge and decision-making processes. The team continues to examine the role of social support in women’s lives, how their relationships with primary care providers and specialists impact their decisions, and more. These innovative uses of inductive research and sociological methods enable this team to translate data about women’s own experiences into recommendations for future changes in clinical practice, health policy and decision support aids.

Second, the team does not assume all women at high breast or ovarian cancer risk will navigate the same route to risk-management decisions. Instead, these research experts overtly examine diversity among high-risk women of different races and socioeconomic status as well as their particular risk types and degrees. Different groups of women make challenging decisions within unique personal, social and cultural contexts, so by examining context, research findings can facilitate future tailoring of the most effective possible methods to improve care for high-risk women.

Third, this team’s research is distinct from work in related areas because it does not focus solely on women recruited from clinical contexts. These scientists have found substantial differences between the decision-making processes and prevention activity of women who are and are not connected to clinical specialists in genetics or breast and ovarian cancer risk. Therefore, Padamsee Group experts develop innovative methodological tools that allow them to learn from the broadest possible range of high-risk women – many of whom would not be captured by research limited to clinical samples.

Participate in the team's latest study of women at high risk of breast or ovarian cancer.

Collaboration With Other Ohio State Labs and Research Teams: Grants and Drug Studies

Most of the Padamsee Group's research is funded by a K01 grant (PI: Padamsee) from the National Cancer Institute, and other grant applications are in process.

When the team is looking for collaborative researchers working in adjacent areas, they look for expertise in cancer prevention, high-risk cancer, health communications, the social context of health decisions, and prevention decision-making. These experts are interested in engaging in collaborative research that uses a range of methodological approaches and where complementary areas of expertise can be put to use to achieve novel aims.

For more information on collaborations, please contact: CPH-DaughterSisterMother@osu.edu.

Contact Us

Tasleem Padamsee

614-688-0986

padamsee.1@osu.edu

Tasleem Padamsee, PhD

 

Dr. Padamsee is a member of the Cancer Control Program at the OSUCCC – James, where she brings a sociological and public health perspective to cancer prevention research.

Learn More